 pharmacokinet disposit zidovudin pregnanc zidovudin pharmacokinet human immunodefici viru type women zidovudin mg week pregnanc postpartum zidovudin concentr high-pressur liquid chromatographi pharmacokinet analys model-independ method pregnant versu postpartum period peak zidovudin level SD mumol/l versu mumol/l elimin half-liv versu area concentr curv mumol/l mumol/l appar total bodi clearanc l/h/kg l/h/kg appar steadi state volum distribut l/kg l/kg umbil cord serum level matern level persist advers effect zidovudin therapi women babi